Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Adenocarcinoma of the Gastroesophageal Junction NCT01196390 On-Study - RTOG 1010 Initial Evaluation Form (I1) - 3088432v1.0 - RTOG 1010 Initial Evaluation Form (I1)

- 17/09/21 - 1 modulo, 8 itemgroups, 88 elementi, 1 linguaggio

Itemgroups: Header Module, Header, Disease Extent, Other Tumor Involvement, BASELINE LABS, EXAMINATIONS / CONSULTATIONS, General Conditions, Footer Module

RTOG 1010 Initial Evaluation Form (I1) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=86E3B1E3-58EB-2570-E040-BB89AD433A07

Adenocarcinoma of the Gastroesophageal Junction NCT01196390 Treatment - RTOG 1010 Post Treatment Response Form (F2) - 3180385v1.0 - RTOG 1010 Post Treatment Response Form (F2)

- 17/09/21 - 1 modulo, 3 itemgroups, 20 elementi, 1 linguaggio

Itemgroups: Header Module, Unnamed 1, Footer Module

RTOG 1010 Post Treatment Response Form (F2) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99087049-39B3-FC29-E040-BB89AD43284B

NCT00655876 F1: Radiation Therapy Oncology Group Phase III Esophagus Followup Form

- 06/02/19 - 1 modulo, 8 itemgroups, 66 elementi, 1 linguaggio

Itemgroups: RTOG clinical trial administrative data, Patient status, Disease Assessment, Disease Events, New Primary, Protocol Specific Adverse Events Evaluation, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS, Footer

NCT00655876 F1: Radiation Therapy Oncology Group Phase III Esophagus Followup Form Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2AA3D242-F366-3171-E044-0003BA3F9857

RTOG 1010 EQ-5D Form and Cover Sheet (HP)

- 02/07/17 - 1 modulo, 4 itemgroups, 25 elementi, 1 linguaggio

Itemgroups: Header Module, EQ-5D Cover Sheet, EQ-5D Health State Measurement, Health State

RTOG 1010 EQ-5D Form and Cover Sheet (HP) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8669CDC0-3163-DDAC-E040-BB89AD431147

Befund ENDO MAG OGDOMAL Sub MS University Hospital Muenster (UKM) Subform

- 01/11/16 - 1 modulo, 1 ItemGroup, 13 elementi, 1 linguaggio

ItemGroup: Colon CA

Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: Befund ENDO MAG OGDOMAL Sub.

Hypopharynx- Esophagram Other documentation diagnostic imaging Routine documentation in German hospitals DMI - Hypopharynx- Esophagram Other documentation diagnostic imaging

- 15/05/16 - 1 modulo, 1 ItemGroup, 7 elementi, 1 linguaggio

ItemGroup: Hypopharynx- Esophagram findings

Routine documentation in German hospitals. Source file name: DG020199_Sonstige Dokumentation bildgebende Diagnostik/ Hypopharyngo-Oesophagogramm.027 Examplary forms provided by DMI (http://www.dmi.de/)

NCT01196390 RTOG 1010 Maintenance Systemic Treatment Summary Form (SF)

- 08/07/15 - 1 modulo, 7 itemgroups, 37 elementi, 1 linguaggio

Itemgroups: Header Module, Summary Of Maintenance Systemic Treatment, Treatment Summary, Therapy Modification, LVEF/ Other Toxicities, Adverse Events, Comments

NCT01196390 RTOG 1010 Maintenance Systemic Treatment Summary Form (SF) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=870A090F-64E8-A152-E040-BB89AD430551

NCT01196390 RTOG 1010 Concurrent Treatment Summary Form (TF)

- 08/07/15 - 1 modulo, 12 itemgroups, 70 elementi, 1 linguaggio

Itemgroups: RTOG clinical trial administrative data, Summary of Concurrent Treatment, Treatment Summary, Therapy Modification, Toxicities, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 8, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 15, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 22, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 29, Adverse Events, Comments

NCT01196390 RTOG 1010 Concurrent Treatment Summary Form (TF) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=870670E5-419D-C79B-E040-BB89AD431B2F

Adenocarcinoma of the Gastroesophageal Junction NCT01196390 Follow-Up - RTOG 1010 Follow-up Form (F1) - 3085847v1.0 - RTOG 1010 Follow-up Form (F1)

- 09/01/15 - 1 modulo, 9 itemgroups, 42 elementi, 1 linguaggio

Itemgroups: Header Module, Header, Current Disease Status, Events, New Primary Cancer, Additional Non Protocol Treatment, Toxicities, Adverse Events, Footer Module

RTOG 1010 Follow-up Form (F1) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=867B6E62-3E34-C9D2-E040-BB89AD4349E3

Adenocarcinoma of the Gastroesophageal Junction NCT01196390 Follow-Up - RTOG 1010 Initial Follow-up Form (FS) - 3088118v1.0 - RTOG 1010 Initial Follow-up Form (FS)

- 09/01/15 - 1 modulo, 8 itemgroups, 39 elementi, 1 linguaggio

Itemgroups: Header Module, Header, Current Disease Status, Events, Toxicities, LVEF Status, Adverse Events, Footer Module

RTOG 1010 Initial Follow-up Form (FS) Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=86E1F1DA-E438-F1B2-E040-BB89AD43175C

Adenocarcinoma of the Gastroesophageal Junction NCT01260701 Registration - Southwest Oncology Group S1005 Registration Worksheet Form - 3163565v1.0 - Southwest Oncology Group S1005 Registration Worksheet Form

- 09/01/15 - 1 modulo, 7 itemgroups, 16 elementi, 1 linguaggio

Itemgroups: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, FOR SWOG INSTITUTIONS, PATIENT INFORMATION, Indicate how the patient answered the following questions on the consent form, Patient Eligibility

Southwest Oncology Group S1005 Registration Worksheet Form MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=966F7821-708F-89E4-E040-BB89AD432062

Adenocarcinoma of the Gastroesophageal Junction NCT01333033 Registration - CALGB-80803 OPEN Registration/Randomization Worksheet (Step 1) - 3287859v1.0 - CALGB-80803 OPEN Registration/Randomization Worksheet (Step 1)

- 09/01/15 - 1 modulo, 6 itemgroups, 15 elementi, 1 linguaggio

Itemgroups: Protocol Administration, Pre-Treatment Characteristics, Certification Of Eligibility, Protocol Design (Stratification Factors), Companion Studies - Study 151007: Molecular Markers of Treatment Response (optional), Companion Studies - Study 71003: Correlation of QOL with Treatment Response and Validation of PRO-CTCAE (optional)

CALGB-80803 OPEN Registration/Randomization Worksheet (Step 1) PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AE28FF1D-7C5B-BC14-E040-BB89AD43491A

Keywords

Sommario

Modelli di dati selezionati